A detailed history of Public Employees Retirement System Of Ohio transactions in Macrogenics Inc stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 25,982 shares of MGNX stock, worth $40,012. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,982
Previous 7,182 261.77%
Holding current value
$40,012
Previous $9,000 244.44%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025

BUY
$1.06 - $1.79 $19,928 - $33,652
18,800 Added 261.77%
25,982 $31,000
Q1 2025

May 14, 2025

SELL
$1.26 - $3.49 $1,365 - $3,783
-1,084 Reduced 13.11%
7,182 $9,000
Q2 2024

Aug 14, 2024

SELL
$3.31 - $18.51 $1,655 - $9,255
-500 Reduced 5.7%
8,266 $35,000
Q1 2024

May 15, 2024

SELL
$9.77 - $21.47 $3,693 - $8,115
-378 Reduced 4.13%
8,766 $129,000
Q4 2023

Feb 15, 2024

SELL
$4.48 - $10.11 $13,440 - $30,330
-3,000 Reduced 24.7%
9,144 $87,000
Q4 2022

Feb 15, 2023

BUY
$3.34 - $6.98 $40,560 - $84,765
12,144 New
12,144 $81,000
Q1 2022

May 16, 2022

BUY
$8.12 - $16.9 $110,602 - $230,194
13,621 Added 16.74%
94,987 $837,000
Q4 2020

Feb 12, 2021

BUY
$19.41 - $26.0 $481,911 - $645,528
24,828 Added 43.91%
81,366 $1.86 Million
Q2 2020

Aug 17, 2020

SELL
$5.2 - $29.12 $62,504 - $350,022
-12,020 Reduced 17.53%
56,538 $1.58 Million
Q4 2019

Feb 14, 2020

BUY
$7.95 - $12.27 $225,462 - $347,977
28,360 Added 70.55%
68,558 $746,000
Q2 2019

Aug 12, 2019

SELL
$14.51 - $19.71 $56,153 - $76,277
-3,870 Reduced 8.78%
40,198 $682,000
Q3 2018

Nov 14, 2018

SELL
$19.26 - $23.46 $156,006 - $190,026
-8,100 Reduced 15.53%
44,068 $945,000
Q1 2018

May 15, 2018

BUY
$18.89 - $32.46 $84,117 - $144,544
4,453 Added 9.33%
52,168 $1.31 Million
Q2 2017

Aug 16, 2017

BUY
N/A
47,715
47,715 $835,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $94.6M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.